Abstract
Importance Functional brain networks are associated with both behavior and genetic factors. To uncover clinically translatable mechanisms of psychopathology, it is critical to define how the spatial organization of these networks relates to genetic risk during development.
Objective To determine the relationship between transdiagnostic polygenic risk scores (PRSs), personalized functional brain networks (PFNs), and overall psychopathology (p-factor) during early adolescence.
Design The Adolescent Brain Cognitive Development (ABCD) Study⍰ is an ongoing longitudinal cohort study of 21 collection sites across the United States. Here, we conduct a cross-sectional analysis of ABCD baseline data, collected 2017-2018.
Setting The ABCD Study® is a multi-site community-based study.
Participants The sample is largely recruited through school systems. Exclusion criteria included severe sensory, intellectual, medical, or neurological issues that interfere with protocol and scanner contraindications. Split-half subsets were used for cross-validation, matched on age, ethnicity, family structure, handedness, parental education, site, sex, and anesthesia exposure.
Exposures Polygenic risk scores of transdiagnostic genetic factors F1 (PRS-F1) and F2 (PRS-F2) derived from adults in Psychiatric Genomic Consortium and UK Biobanks datasets. PRS-F1 indexes liability for common psychiatric symptoms and disorders related to mood disturbance; PRS-F2 indexes liability for rarer forms of mental illness characterized by mania and psychosis.
Main Outcomes and Measures (1) P-factor derived from bifactor models of youth- and parent-reported mental health assessments. (2) Person-specific functional brain network topography derived from functional magnetic resonance imaging (fMRI) scans.
Results Total participants included 11,873 youths ages 9-10 years old; 5,678 (47.8%) were female, and the mean (SD) age was 9.92 (0.62) years. PFN topography was found to be heritable (N=7,459, 57.06% of vertices h2 pFDR<0.05, mean h2=0.35). PRS-F1 was associated with p-factor (N=5,815, r=0.12, 95% CI [0.09–0.15], p<0.001). Interindividual differences in functional network topography were associated with p-factor (N=7,459, mean r=0.12), PRS-F1 (N=3,982, mean r=0.05), and PRS-F2 (N=3,982, mean r=0.08). Cortical maps of p-factor and PRS-F1 regression coefficients were highly correlated (r=0.7, p=0.003).
Conclusions and Relevance Polygenic risk for transdiagnostic adulthood psychopathology is associated with both p-factor and heritable PFN topography during early adolescence. These results advance our understanding of the developmental drivers of psychopathology.
Question What is the relationship between transdiagnostic polygenic risk scores (PRSs), personalized functional brain networks (PFNs), and overall psychopathology (p-factor) during early adolescence?
Findings In this cross-sectional analysis of the Adolescent Brain Cognitive Development (ABCD) Study⍰ (N=11,873, ages 9-10), we found that a PRS of common psychopathology in adulthood (PRS-F1) was associated with p-factor during early adolescence. Interindividual differences in p-factor, PRS-F1, and PRS-F2 (capturing rarer psychopathology in adulthood) were all robustly associated with PFN topography.
Meaning Polygenic risk for transdiagnostic adulthood psychopathology is associated with both p-factor and PFN topography during early adolescence.
Competing Interest Statement
AAB has received consulting income from Octave Bioscience. JS and AAB hold shares in and JS is a director of Centile Bioscience Inc.
Funding Statement
This study was funded by 1F30MH138048-01, 5R01MH132934-02, 5R01MH113550-07, 5R01MH120482-03, 5U01MH119690, 1K08MH135343, 5R01EB022573, 5T32MH019112-32, 1L30MH131061-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of California, San Diego gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Senior authors
Updated formatting of abstract on webpage, updated figure legend
Data Availability
Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development Study® (https://abcdstudy.org), held in the NIMH Data Archive (NDA). Only researchers with an approved NDA Data Use Certification (DUC) may obtain ABCD Study data.
